Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01089803 · ClinicalTrials.gov registry record
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
A clinical trial of Squamous Cell Carcinoma and Laryngeal Cancer, sponsored by University of Minnesota.
- Completed
- Registry status
- 279
- Enrollment target
- 1
- Study location
NCT01089803 is a study of Squamous Cell Carcinoma and Laryngeal Cancer that has completed, run by University of Minnesota. The registered enrollment target is 279 participants, above the 98-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (185% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01089803, a study of Squamous Cell Carcinoma and Laryngeal Cancer, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 279 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective, multi-institutional, observational cohort study is to determine if an initial surgical approach leads to better function and quality of life than primary chemoradiation in a subset of patients with advanced hypopharyngeal and laryngeal cancers.
Conditions Studied
Study Locations (1)
Minnesota
- Masonic Cancer Center, University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01089803
The ClinicalTrials.gov registry entry for NCT01089803 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (185% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT01089803 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01089803 about?
NCT01089803 is a clinical study titled "Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer". The purpose of this prospective, multi-institutional, observational cohort study is to determine if an initial surgical approach leads to better function and quality of life than primary chemoradiation in a subset of patients with advanced hypopharyngeal and laryngeal cancers.
What is the current status of trial NCT01089803?
This trial is currently completed. The enrollment target is 279 participants. The study started on 2009-09. Estimated completion is 2015-08.
What conditions does trial NCT01089803 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Laryngeal Cancer.
Who is sponsoring clinical trial NCT01089803?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01089803 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
RECRUITING · Phase 2
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Toripalimab With Chemotherapy for Sinus Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.